Medical Videos ppt and Lecture Notes: Feb 19, 2012

25 February 2012

Pulmonary artery occlusion pressure

Pulmonary Hypertension
https://pediatrics.med.unc.edu/education/uncpeds/rotations/picu/files/PHTN_Resident_Lecture.ppt

Use of Thrombolytics in Pulmonary Embolism
http://intmedweb.wfubmc.edu/download/thrombolytics.ppt.

The Use of Thrombolytics in Pulmonary Embolism
by Pamela Harm, M.D.
http://intmedweb.wfubmc.edu/download/thrombolytics.ppt

Pulmonary Blood Flow
by Thomas Sisson, M.D.
http://open.umich.edu/sites/default/files/2319/tsisson-pulmonarybloodflow-07-1.ppt

Control of Cardiac Output
by Daniel R. Margulies, MD, FACS
Crirtical care.ppt

Invasive Hemodynamic Monitoring
Donna Cohen, BSN, RN
Hemodynamic Pre and Dynamic

Anesthetic Management of Vascular Surgery
Vascular Surgery.ppt

Controversies in Pulmonary Hypertension and Sickle Cell Disease
By Kristen Sanfilippo MD
Sanfilippo_2011-10-28.ppt

Heart, Blood, & Lymph Disease
http://occonline.occ.cccd.edu/online/dfarrell/HeartBloodLymph.PPT

Pediatric Cardiac Disorders
pp_cardiac.ppt

Pulmonary Artery Catheter
by Marie Sankaran Raval M.D.
Pulmonary Artery Catheter.ppt

Cardiovascular Nursing
Cardiovascular Cardiovascular.ppt

Central Venous Pressure Monitoring
By Dr. Aidah Abu Elsoud Alkaissi
Central Venous Pressure.ppt

Cardiac Pathophysiology
Cardiac Pathophysiology.ppt

Toxoplasmosis Ppts and recent articles

Toxoplasmosis is an infectious disease caused by protozoan parasite Toxoplasma gondii.

Major Human Parasites
Major human Protozoa.ppt

Eye manifestations during pregnancy
By Dr Mohamed Abusharifa, MD
Eye-manifestations-during-pregnancy.ppt

Ocular Toxoplasmosis: A Common Manifestation of a Not-So-Common Disease
Mehdi Shahidi, MD, Vidya Sundareshan, MD, MPH
Ocular Toxoplasmosis .ppt

Toxoplasmosis
by Pam Holmes, Christy Stalcup, and Pam Yarborough
Toxoplasmosis.ppt

New Molecular Based Methods of Diagnosis
Molecular Methods of Diagnosis.ppt

Toxoplasmosis
http://www.uic.edu/depts/ci/neonat05/Handouts/TH6-CMV05-Pyati.ppt

Infectious Mononucleosis
http://cls.umc.edu/COURSES/CLS311/InfMono.ppt

Systemic Diseases and the Eye
Systemic Diseases and the Eye

Anti-protozoal drugs
http://elearning.najah.edu/OldData/pdfs/4518antiparasitics%201.ppt

24 February 2012

Free access to Pharmacological Reports

Pharmacological Reports until 2004 known as Polish Journal of Pharmacology.

Scope of the journal. The Pharmacological Reports, formerly Polish Journal of Pharmacology, publishes papers concerning all aspects of pharmacology, dealing with the drug action at the cellular and molecular level, and papers on relationship between molecular structure and biological activity. The language of all publications is English.

Free full text access from 2001 onwards. From 1998 to 2000 abstracts only available

http://www.if-pan.krakow.pl/pjp/index.html

Clinical Laboratory Ppts

Medullary Thyroid Cancer Ppts and Recently published articles

Medullary Thyroid Cancer
by Travis Baggett
http://www.bcm.edu/sims/Files/vignette2.ppt

Surgical Treatment of Medullary Carcinoma of the Thyroid
by Jacques Peltier MD, Francis B. Quinn, MD
CA-thyroid-slides-070120.ppt

Pediatric Thyroid Malignancies
by Kristen Boyle, MD
ModificationDate=1264544885803

Evaluation of a Thyroid Nodule
by Michael E. Decherd, MD, Matthew W. Ryan, MD
http://med.mui.ac.ir/clinical/ent/Thyroid-Nodule-2002-01-slides.ppsx

Update in the Management of Thyroid Neoplasms
by David R. Byrd, MD
http://depts.washington.edu/surgstus/Clerkship/Lectures/print/Thyroid_Byrd.ppt

Medullary Thyroid Cancer
by David M. Gleinser, MD, Susan D. McCammon, MD
Thyroid-ca-slides-101027.ppt

Thyroid Cancer
by Christopher Muller
ThyroidCA-9810.ppt

Evaluation of Thyroid Nodules
by Eric Oliver
RadiologyThyroid.ppt

Evaluation of the Effects of Low Dose Radiation-dose reconstruction
by Lynn R. Anspaugh, Ph.D
Anspaugh-Radiation_Dose_Reconstruction.ppt

Evaluation of Thyroid Nodules
by Michael L. Tuggy, MD
Thyroid nodules.ppt

Pathology of the Thyroid Gland
by Prof. Dipak Shah
Thyroiddiseases.ppt

Tissue Damaged By Heart Attack Could Be Repaired By Injectable Gel

Tissue Damaged By Heart Attack Could Be Repaired By Injectable Gel

The hydrogel is made from cardiac connective tissue that is stripped of heart muscle cells through a cleansing process, freeze-dried and milled into powder form, and then liquefied into a fluid that can be easily injected into the heart. Once it hits body temperature, the liquid turns into a semi-solid, porous gel that encourages cells to repopulate areas of damaged cardiac tissue and to preserve heart function, according to Christman. The hydrogel forms a scaffold to repair the tissue and possibly provides biochemical signals that prevent further deterioration in the surrounding tissues.

"It helps to promote a positive remodeling-type response, not a pro-inflammatory one in the damaged heart," Christman said.

The study by Karen Christman and colleagues published in the Journal of the American College of Cardiology.

Read full article
http://content.onlinejacc.org/cgi/content/abstract/59/8/751

23 February 2012

Blood test that tells you how long you'll live

The controversial test measures vital structures on the tips of a person's chromosomes, called telomeres, which scientists believe are one of the most important and accurate indicators of the speed at which a person is ageing.

Scientists behind the €500 (£435) test said it will be possible to tell whether a person's "biological age", as measured by the length of their telomeres, is older or younger than their actual chronological age.

Medical researchers believe that telomere testing will become widespread within the next five or 10 years, but there are already some scientists who question its value and whether there should be stronger ethical controls over its wider use. In addition to concerns about how people will react to a test for how "old" they really are, some scientists are worried that telomere testing may be hijacked by unscrupulous organisations trying to peddle unproven anti-ageing remedies and other fake elixirs of life.

The results of the tests might also be of interest to companies offering life-insurance policies or medical cover that depend on a person's lifetime risk of falling seriously ill or dying prematurely. However, there is a growing body of scientific opinion that says testing the length of a person's telomeres could provide vital insights into the risk of dying prematurely from a range of age-related disorders, from cardiovascular disease to Alzheimer's and cancer. "We know that people who are born with shorter telomeres than normal also have a shorter lifespan. We know that shorter telomeres can cause a shorter lifespan," said Maria Blasco of the Spanish National Cancer Research Centre in Madrid, who is the inventor of the new commercial telomere test. "But we don't know whether longer telomeres are going to give you a longer lifespan. That's not really known in humans," she added.

Telomeres: a short history
* 2003 Scientists studying 20-year-old blood samples from 143 people show that telomere length is good indicator of whether someone is likely to live for 15 years or more once they reach 60.

* 2004 Women living with stress of having a sick child are found to have shorter telomeres. Other research suggests that meditation or other forms of stress reduction may lengthen telomeres.

* 2007 Study of men in Scotland shows those with the longest telomeres were half as likely to develop heart disease than those with shorter telomeres. Telomere length was as good as cholesterol levels at predicting the risk of developing cardiovascular disease.

* 2009 Short telomeres linked with inherited bone marrow disease.

* 2010 GM mice with no telomerase, an enzyme that elongates telomeres in some cells, age prematurely compared to normal mice. The ageing effects were reversed after injections of telomerase.

Source

Borrelia burgdorferi Lyme Disease

Borrelia burgdorferi is a spirochete which is the causative agent of Lyme disease, the most common tick-borne disease in the United States.

Diagnosis of Lyme Disease
http://instructional1.calstatela.edu/nmcquee/Micro302/Group%20cases/Case%2038.ppt

Infectious Arthritis
https://medicine.med.unc.edu/education/internal-medicine-residency-program/files/ppt/8.3.09%20Jonas%20Infectious%20Arthritis.ppt

Lyme Disease and The Lyme Disease Vaccine
By Jason Hadrath
http://www.chem.uwec.edu/Chem412_S99/ppt/lyme.ppt

Lyme’s Disease
http://www.austincc.edu/kotrla/serLymesDisease.ppt

Homology modeling of enolase in Borrelia burgdorferi
by Andrew Jones, Brenden O’Connell, Martine Stewart, Edwin Suh and Amy Schumer
http://s11.middlebury.edu/MBBC0324A/STUDENTS/Structure_II/Protein_Homology_II.ppt

Lyme Disease
http://www.columbia.edu/itc/hs/nursing/m8770/2003/infectious%20diseases.ppt

Treatment of Nervous System Lyme Disease (An Evidence-Based Review)
http://www.aan.com/practice/guideline/index.cfm?fuseaction=home.view&guideline=249

Borrelia burgdorferi Lyme disease
http://www2.yk.psu.edu/~mph13/Borrelia%20burgdorferi.ppt

Borrelia Burgdorferi Lyme Disease
by Joenay M. Latoya B., Diamante C.
http://www.elmhurst.edu/library/courses/workshoppages//BorreliaBurgdorferi1.ppt

Lyme’s Disease
http://www.austincc.edu/kotrla/serLymesDisease.ppt

Transmitted Microbial Diseases
http://people.uncw.edu/sizemorer/rkswww/PP%202011/17d%20Transmitted%20Microbial%20Diseases.ppt

Lyme Disease “The most common tickborne infection in the United States"
http://www.plu.edu/~eatonla/doc/lyme-disease.ppt

21 February 2012

Proprioceptive Neuromuscular Facilitation - PNF Ppt and Published articles

PNF - Propriocpetive neuromuscular facilitation is exercise based on the principles of functional human anatomy and neurophysiology

Muscle Strength and Endurance
http://users.rowan.edu/

Proprioceptive Neuromuscular Facilitation When and Why?
PNFstretch.ppt

Warm-Up and Stretching
by Ian Jeffreys, MS; CSCS, NSCA-CPT
warmup.09.ppt

Proprioceptive Neuromuscular Facilitation
PNF patterns.ppt

Restoring Range of Motion and Improving Flexibility Importance of Flexibility
Improving Flexibility.ppt

Training and Conditioning Techniques
http://www.iwu.edu/~bkauth/firstaid/326-2.ppt

Principles of Flexibility
Flexibility.ppt

Lecture Notes in pdf format

20 February 2012

Jaundice (Kamala in Ayurveda Manjal Kaamalai in Siddha) Clinical Trials and conditions

1 Human Kidney Histopathology in Obstructive Jaundice

Condition: Patients With Obstructive Jaundice

2 Breastfeeding Support Intervention in Jaundiced Infants

Conditions: Jaundice; Breastfeeding

3 Immune Function in Patients With Obstructive Jaundice

Conditions: Obstructive Jaundice; Disease as Reason for ERCP; Immune Dysfunction; Immune

4 Transcutaneous Bilirubinometers in the Community

Condition: Jaundice, Neonatal

5 Role of Endoscopic RFA in Prolonging the Patency of Metal Stents in Patients With Malignant Obstructive Jaundice

Conditions: Jaundice Extrahepatic Obstructive; Disorder of Bile Duct Stent

6 Transcutaneous Bilirubinometry in Healthy Term and Near-Term Neonates

Condition: Hyperbilirubinemia

7 Transcutaneous Measurement of Jaundice in the Newborn

Conditions: Hyperbilirubinemia, Neonatal; Jaundice, Neonatal

8 Treatment of Neonatal Jaundice With Filtered Sunlight Phototherapy: Safety and Efficacy in African Neonates

Condition: Jaundice, Neonatal

9 Randomised Trial Comparing Metal and Plastic Biliary Stents Stents for Palliating Malignant Jaundice

Condition: Biliary Obstruction

10 Safety and Efficacy of Photodynamic Therapy for Bile Duct Invasion of Hepatocellular Carcinoma

Conditions: Hepatocellular Carcinoma; Obstructive Jaundice

11 Prediction of Jaundice in Term Infants

Conditions: Infant, Newborn; Jaundice

12 Evaluation of Immune Function in Biliary Atresia Children With Prolonged Jaundice

Condition: Biliary Atresia

13 Comparison Between Internal and External Preoperative Biliary Drainage in Periampullary Cancers

Conditions: Periampullary Cancers Causing Obstructive Jaundice; Pancreas Head Cancer; Bile Duct Cancer; Carcinoma of Ampulla of Vater

14 Malignant Obstruction ZILVER Against Routine Therapy (MOZART I)

Conditions: Biliary Tract Neoplasms; Pancreatic Neoplasms; Jaundice, Obstructive

15 Compassionate Use of Stannsoporfin in Addition to Phototherapy to Reduce the Need for Exchange Transfusions in Term and Near-Term Infants

Conditions: Neonatal Hyperbilirubinemia; Neonatal Jaundice; Jaundice; Hyperbilirubinemia

16 Measurement of Carboxyhemoglobin by Gas Chromatography as an Index of Hemolysis

Conditions: ABO Incompatibility; Hemolytic Disease of Newborn; Neonatal Jaundice; Neonatal Hyperbilirubinemia

17 Effect of Timing of Umbilical Cord Clamping on Haematological and Clinical Outcomes of Infants

Conditions: Anemia; Ferritin; Complications; Hemorrhage; Jaundice

18 Endoscopic Versus Percutaneous Drainage For Hilar Block in Gall Bladder Cancer

Conditions: Gallbladder Cancer; Obstructive Jaundice

19 Comparison of Metal and Plastic Stents for Preoperative Biliary Decompression

Conditions: Obstructive Jaundice; Pancreatic Cancer

20 Stenting Malignant Jaundice for Quality of Life

Condition: Bile Duct Neoplasms Malignant

21 Prospective Randomized Study of PTC and EUS-guided Drainage of the Bile Duct

Condition: Jaundice

22 Compassionate Use of Stanate (TM) [Stannsoporfin]

Conditions: Neonatal Jaundice; Hyperbilirubinemia

23 Efficacy of Zinc in Reducing Hyperbilirubinemia Among High Risk Neonates - A Double Blind Randomized Trial

Condition: Neonatal Jaundice

24 Demographic, Metabolic, and Genomic Description of Neonates With Severe Hyperbilirubinemia

Conditions: Hyperbilirubinemia; Jaundice

25 ComVi Stent Versus Uncovered Self-Expandable Metal Stent (SEMS) for Biliary SEMS Occlusion

Conditions: Biliary Tract Neoplasms; Jaundice, Obstructive

Interventions: Device: ComVi stent; Device: Uncovered SEMS

Outcome Measure: Time to stent occlusion

26 A Prospective, Randomized Study Evaluating the Effect of Biliary Stenting on EAU-FNA in Patients With Suspected Malignant Biliary Obstruction

Condition: Jaundice

27 Expression of BCRP in Icteric Patients

Condition: Icterus

28 Endoscopic Ultrasound Versus Endoscopic Retrograde Cholangiopancreatography (ERCP) Tissue Sampling for the Diagnosis of Suspected Pancreatico-Biliary Cancer

Conditions: Pancreaticobiliary Cancers; Jaundice; Bile Duct Obstruction

29 Acute Viral Hepatitis and Diabetes Mellitus

Conditions: Acute Viral Hepatitis; Diabetes Mellitus

30 Outcome of Carbon Dioxide Versus Air Insufflations During Endoscopic Retrograde Cholangiopancreatography (ERCP)

Condition: Obstructive Jaundice

31 Interventional Endoscopy Database for Pancreatico-biliary, Gastrointestinal and Esophageal Disorders

Conditions: Ampullary Cancer; Duodenal Cancer; Bile Duct Cancer; Bile Duct Disorders; Gallstones; Obstructive Jaundice; Pancreatic Disorders (Noncancerous); Colorectal Cancer; Esophageal Cancer; Barrett's Esophagus; Gastric Malignancies; Pancreatic Cancer; Pediatric Gastroenterology; Cholangiocarcinoma; Pancreatic Pseudocysts; Acute and Chronic Pancreatitis; Recurrent Pancreatitis; Cholangitis; Bile Leak; Biliary Strictures; Pancreatic Divisum; Biliary and Pancreatic Stones; Choledocholithiasis

32 Trial of Aggressive Versus Conservative Phototherapy in Infants <1,000 Grams Birth Weight

33 Improving Health Outcomes for New Mothers and Babies

34 Effect of Benadryl Sedation During ERCP or EUS

Conditions: Gallbladder Disease; Gallstones; Pancreatitis; Abdominal Pain; Jaundice

35 Observational Study of Infants Born at 34 to 37 Weeks of Gestation Until the Age of 1 Year

36 Comparing Endoscopic Based Stent Strategy Versus Bypass Surgery in Non-resectable Periampullary Cancer

Conditions: Pancreatic Neoplasms; Biliary Tract Neoplasms; Duodenal Neoplasms

37 RCT Steel (Wallstent®) vs Nitinol (Wallflex®) Bile Duct Stent for Palliation of Malignant Obstruction

Conditions: Biliary Tract Neoplasms; Pancreatic Neoplasms; Stents

38 Light-emitting Diodes (LED) Phototherapy for Hyperbilirubinemia of Term Newborn

Condition: Hyperbilirubinemia

39 Comparison of Biliary Stenting Alone vs. Stenting With Photodynamic Therapy During ERCP

Condition: Cholangiocarcinoma

40 Covered or Uncovered Bile Duct Stents

Condition: Bile Duct Neoplasms

41 A Trial Comparing the Uncovered to the Covered Wallstent in the Palliation of Malignant Bile Duct Strictures

Condition: Inoperable Tumors of the Bile Duct

42 The Effect of Hyperbilirubinemia on CV Disease, Neurocog Function and Renal Function

Condition: HIV

43 Atazanavir/Ritonavir and Zinc Pharmacokinetic Study

Condition: HIV Infection

44 Reverse Phototherapy With Super Light-emitting Diode(Super-LED) for Hyperbilirubinemia in Term and Late Preterm Infants

45 Safety and Pharmacology of Stanate

Condition: Hyperbilirubinemia

46 GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Conditions: Adenocarcinoma of the Pancreas; Advanced Solid Tumors; Cancer; Cancer of Pancreas; Cancer of the Pancreas; Metastases; Metastatic Cancer; Metastatic Pancreatic Cancer; Pancreas Cancer; Pancreatic Cancer; Bone Metastases; Endocrine Cancer; Oncology; Oncology Patients; Solid Tumors; Advanced Malignancy

47 Early Versus Delayed Cord Clamping at Term: Outcomes in Swedish Infants

Conditions: Iron Deficiency; Neonatal Hyperbilirubinemia

48 RCT of Steroids Following Kasai Portoenterostomy for Biliary Atresia.

Condition: Biliary Atresia

49 Comparing Covered Self-expandable Metallic Stent (SEMS) Above/Across the Sphincter of Oddi

Conditions: Cancer of Bile Duct; Pancreatic Cancer

50 Study of Long-Term Peg Intron Vs. Colchicine in Non-Responders.

51 Covered Self-expandable Metal Stents for Palliation of Malignant Biliary Strictures: Evaluation of a New Type of Stent

Condition: Malignant Biliary Strictures

Intervention: Device: Endoscopic retrograde cholangiography (ERC) (ComVi biliary stent)

52 Umbilical Cord Milking on the Reduction of Red Blood Cell Transfusion Rates in Infants

Condition: Prematurity